ATE193439T1 - Kontrolliertes pharmazeutisches präparat zur gezielten freisetzung eines medizinischen wirkstoffes im intestinaltrakt - Google Patents

Kontrolliertes pharmazeutisches präparat zur gezielten freisetzung eines medizinischen wirkstoffes im intestinaltrakt

Info

Publication number
ATE193439T1
ATE193439T1 AT95103493T AT95103493T ATE193439T1 AT E193439 T1 ATE193439 T1 AT E193439T1 AT 95103493 T AT95103493 T AT 95103493T AT 95103493 T AT95103493 T AT 95103493T AT E193439 T1 ATE193439 T1 AT E193439T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
intestinal tract
active ingredient
active substance
medicinal active
Prior art date
Application number
AT95103493T
Other languages
English (en)
Inventor
Yoshiyuki Hirakawa
Hiroyuki Yoshino
Eiji Fukui
Tami Nee Komoda Tami Hanamori
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12593695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE193439(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE193439T1 publication Critical patent/ATE193439T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95103493T 1994-03-11 1995-03-10 Kontrolliertes pharmazeutisches präparat zur gezielten freisetzung eines medizinischen wirkstoffes im intestinaltrakt ATE193439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6040911A JP2917799B2 (ja) 1994-03-11 1994-03-11 消化管内適所放出型製剤

Publications (1)

Publication Number Publication Date
ATE193439T1 true ATE193439T1 (de) 2000-06-15

Family

ID=12593695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95103493T ATE193439T1 (de) 1994-03-11 1995-03-10 Kontrolliertes pharmazeutisches präparat zur gezielten freisetzung eines medizinischen wirkstoffes im intestinaltrakt

Country Status (14)

Country Link
US (1) US5725880A (de)
EP (1) EP0671168B1 (de)
JP (1) JP2917799B2 (de)
KR (1) KR100305234B1 (de)
CN (1) CN1116523A (de)
AT (1) ATE193439T1 (de)
CA (1) CA2144094C (de)
DE (1) DE69517218T2 (de)
DK (1) DK0671168T3 (de)
ES (1) ES2148365T3 (de)
GR (1) GR3033593T3 (de)
PT (1) PT671168E (de)
SG (1) SG34210A1 (de)
TW (1) TW422708B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120354B1 (es) * 1996-02-12 1999-07-01 Univ Sevilla Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP1101490B1 (de) * 1998-07-28 2005-04-13 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
FR2790387B1 (fr) * 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
WO2001054671A1 (fr) * 2000-01-27 2001-08-02 Tanabe Seiyaku Co., Ltd. Preparation a liberation prolongee et son procede de fabrication
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
EP1272165B1 (de) * 2000-02-10 2010-12-01 BPSI Holdings, Inc. Acrylzusammensetzungen zur enterischen beschichtung
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
WO2007010846A1 (ja) * 2005-07-15 2007-01-25 Kissei Pharmaceutical Co., Ltd. 胃内滞留製剤
PL2278002T3 (pl) * 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
SI1931316T1 (sl) 2005-08-15 2010-06-30 Solvay Pharm Gmbh Farmacevtski sestavki z nadzorovanim sproščanjem za kislinsko labilna zdravila
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
JPWO2008087882A1 (ja) * 2007-01-15 2010-05-06 キッセイ薬品工業株式会社 胃内滞留型レボドパ徐放性製剤
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
EP2392321A1 (de) 2007-06-13 2011-12-07 Jay Pravda Kombinationspräparat zur rektalen Verabreichung zur Behandlung von entzündlicher Darmerkrankung
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CA2739465C (en) 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2255794A1 (de) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Magensaftresistenter Überzug
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
US10765635B2 (en) * 2018-02-06 2020-09-08 Nano Pharmaceutical Laboratories Llc Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form
US20240189236A1 (en) * 2021-07-09 2024-06-13 Evonik Operations Gmbh Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3608030A (en) * 1969-05-21 1971-09-21 Howard Tint Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
CA1308357C (en) * 1987-01-28 1992-10-06 Tohru Chiba Method for the preparation of a coated solid medicament
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition

Also Published As

Publication number Publication date
DE69517218D1 (de) 2000-07-06
TW422708B (en) 2001-02-21
EP0671168A1 (de) 1995-09-13
EP0671168B1 (de) 2000-05-31
KR100305234B1 (ko) 2002-04-24
CA2144094C (en) 2004-01-27
US5725880A (en) 1998-03-10
CA2144094A1 (en) 1995-09-12
PT671168E (pt) 2000-09-29
DK0671168T3 (da) 2000-08-07
JP2917799B2 (ja) 1999-07-12
JPH07247222A (ja) 1995-09-26
KR950031046A (ko) 1995-12-18
DE69517218T2 (de) 2000-11-30
GR3033593T3 (en) 2000-09-29
ES2148365T3 (es) 2000-10-16
SG34210A1 (en) 1996-12-06
CN1116523A (zh) 1996-02-14

Similar Documents

Publication Publication Date Title
DE69517218D1 (de) Kontrolliertes pharmazeutisches Präparat zur gezielten Freisetzung eines medizinischen Wirkstoffes im Intestinaltrakt
MX9500885A (es) Preparacion farmaceutica para administracion oral.
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
KR970703151A (ko) 알렌드로네이트의 경구 액상 제형(Oral liquid alendronate formulations)
CA2390377A1 (en) Method and apparatus for delivery of controlled doses of therapeutic drugs in endoluminal procedures
DE69727153D1 (de) Im magen verweilende orale arzneistoffdosisformen zur gesteuerten freisetzung schwerlöslicher arzneistoffe und unlöslicher stoffe
NO20003640L (no) Ny doseringsform
WO1998056360A3 (en) Film-coated tablet for improved upper gastrointestinal tract safety
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
US7445795B2 (en) Delivery device, method of using and method of manufacturing
DE69920689D1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
DE69532678D1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende Arzneimittel
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
ES2149250T3 (es) Dispositivo para la administracion de medicamentos con liberacion controlada.
NO940376D0 (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
ATE238774T1 (de) Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
ATE357231T1 (de) Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung
JP3438110B2 (ja) 家畜用錠剤
GB2365336A (en) Multiple capsules
EP1062946A4 (de) Heilmittel und prophylaxe von störungen der intestinalen schleimhäute
JP2001514218A5 (de)
WO2017090902A1 (ko) 구강 지혈 및 상처 보호 필름
RU2001131112A (ru) Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты
RU99127466A (ru) Сферические микрогранулы с контролируемым высвобождением с задержкой в желудке для улучшенной доставки лекарственных препаратов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked